Sign in

CIK 0001619856 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Caribou Biosciences, Inc.

Sign in to watch
Ticker
CRBU
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
453728228
Phone
510-982-6030
Business address
2929 7TH STREET, SUITE 105, BERKELEY, CA, 94710
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 3 Insider Initial Statement of Ownership
  4. 10-Q Report Quarterly Report
  5. 8-K Event Results of operations
  6. 3 Insider Initial Statement of Ownership
  7. 8-K Event Executive or director change · Regulation FD disclosure
  8. 4 Open-market buy Chief Legal Officer bought 9,219 shares at $2.69 ($24,799)
  9. 4 Open-market buy Chief Scientific Officer bought 114,860 shares at an average $1.92 ($220,757)
  10. 4 Open-market buy VP of Finance and Controller bought 1,746 shares at $2.69 ($4,697)
  11. 4 Derivatives Options or other derivatives
  12. 3 Insider Initial Statement of Ownership
  13. 8-K Event Executive or director change · Regulation FD disclosure
  14. 4 Derivatives Options or other derivatives
  15. 10-Q Report Quarterly Report
  16. 8-K Event Results of operations
  17. 3 Insider Initial Statement of Ownership
  18. 8-K Event Executive or director change · Regulation FD disclosure
  19. SC 13G Stake Amended Statement of Ownership
  20. SC 13G Stake Amended Statement of Ownership

Page 14 of 17 · 326 filings